The epidemiology of Proteus hauseri infection, as this species is relatively rare and often misidentified as Proteus vulgaris bio group 3—however, some general aspects of the epidemiology of Proteus spp. Infection can be applied to Proteus hauseri infection as well.
Proteus spp. is widely distributed in nature and can be found in soil, water, and fecal matter. They are also part of the average human intestinal flora and other Enterobacteriaceae such as Escherichia coli and Klebsiella spp. Proteus spp. are opportunistic pathogens that can cause human infections when they breach the mucosal barriers or enter the bloodstream through wounds, catheters, or other medical devices.
The most common infection caused by Proteus spp. is urinary tract infection (UTI), which may impact any area of the urinary system, including the urethra to the kidney. UTI can occur due to bacterial migration from the rectum to the periurethral and bladder or catheter-associated infection. UTI can also lead to complications such as urolithiasis (stone formation in the kidney or bladder), pyelonephritis (kidney inflammation), cystitis (bladder inflammation), and septicemia (blood infection). Other infections caused by Proteus spp. Including wound infections, burn infections, respiratory tract infections, ear infections, eye infections, meningitis, endocarditis, and osteomyelitis. These infections are more likely to occur in immunocompromised patients or patients with chronic diseases, such as diabetes, liver disease, or renal failure.
Proteus hauseri is one of the five named species of Proteus, along with P. mirabilis, P. vulgaris, P. penneri, and P. myxofaciens. P. hauseri was formerly known as P. vulgaris group 3 or P. vulgaris genomospecies three but was renamed in 2000 based on molecular and phenotypic evidence. P. hauseri has been isolated from various clinical specimens, such as urine, pus, blood, and sputum. It has also been associated with infections such as UTI, wound infection, septicemia, and brain abscess.
The prevalence and incidence of Proteus hauseri infection have yet to be well known, as this species is often misidentified or overlooked in clinical microbiology laboratories. However, some studies have reported that Proteus hauseri accounts for about 1% to 5% of all Proteus isolates from clinical specimens. The risk factors for Proteus hauseri infection are like those for other Proteus spp., such as urinary tract abnormalities, urethral instrumentation, immunosuppression, chronic diseases, and hospitalization.
Proteus hauseri is a Gram-negative bacterium belonging to the family Enterobacteriaceae. It is a motile, facultative anaerobe commonly found in the environment, particularly in water and soil.
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Proteus
Species:Proteus hauseri
Proteus hauseri is a rod-shaped bacterium with a size ranging from 0.5 to 0.8 micrometers in width and 1.5 to 3 micrometers in length. It has a single, polar flagellum, which enables it to exhibit a characteristic swarming motility on agar plates. The flagella allow Proteus hauseri to move rapidly through liquid media or solid surfaces.
Like other Gram-negative bacteria, Proteus hauseri has an outer membrane, a thin peptidoglycan layer in the cell wall, and a plasma membrane. The outer membrane provides an additional protective barrier and contains various proteins and lipopolysaccharides (LPS), which play a role in pathogenesis and immune response.
Proteus hauseri can produce a capsule, a polysaccharide layer that surrounds the cell wall. The capsule helps the bacterium evade the host’s immune system and contributes to its pathogenicity.
Regarding biochemical characteristics, Proteus hauseri is facultatively anaerobic, meaning it can grow both in the presence and absence of oxygen. It is also able to ferment glucose and produce acid and gas. Additionally, Proteus hauseri is urease-positive, which means it can hydrolyze urea and produce ammonia, increasing pH in the surrounding environment.
Proteus hauseri has two antigenic structures: O antigens and H antigens. O antigens are somatic antigens that are part of the cell wall lipopolysaccharide (LPS) and are heat stable. H antigens are flagellar antigens associated with the motility of the bacteria and are heat labile.
Based on these antigens, several serotypes of Proteus hauseri have been recognized, such as O1 to O17, and H2 are all types of atoms. Some of these serotypes cross-react with other bacteria, such as Rickettsia spp., Salmonella spp., and Shigella spp.
Some strains of Proteus hauseri that have been isolated and characterized are:
ATCC 700826T, the strain type of Proteus hauseri, was isolated from a human wound in the USA. This strain has been whole genome sequenced and has applications in quality control and water testing.
NCTC 4175, a Proteus hauseri strain isolated from a human urine sample in Germany. This strain is also known as strain Lehmann and has been whole genome sequenced.
CDC 1732-80, a Proteus hauseri strain isolated from a human blood sample in the USA.
CIP 106868, a Proteus hauseri strain isolated from a human urine sample in France.
DSM 14437, a Proteus hauseri strain isolated from a human wound in the USA.
Pathogenesis is the process by which a microorganism causes disease in a host. The pathogenesis of Proteus hauseri infections involves the following steps:
Entry:Proteus hauseri can enter the host through different routes, such as ingesting contaminated food or water, direct contact with infected people or animals, or colonization of medical devices such as catheters or nasogastric tubes.
Adhesion:Proteus hauseri can adhere to the host cells and tissues using various adhesins, such as pili (fimbriae), flagella, and outer membrane proteins. Adhesion is essential for colonization, invasion, and biofilm formation.
Invasion:Proteus hauseri can invade the host cells and tissues using various mechanisms, such as endocytosis, transcytosis, paracellular migration, or direct penetration. Invasion is essential for escaping the host immune system and reaching deeper sites of infection.
Damage:Proteus hauseri can damage the host cells and tissues using various mechanisms, such as the production of urease, proteases, hemolysins, and lipases. Ureases can increase urine pH and cause kidney stones and tissue damage. Proteases can degrade host proteins and extracellular matrix. Hemolysins can lyse host red blood cells and cause anemia. Lipases can hydrolyze host lipids and cause inflammation.
Evasion:Proteus hauseri can evade the host immune system using various mechanisms, such as antigenic variation, biofilm formation, intracellular survival, and resistance to antimicrobial agents. Antigenic variation can prevent recognition by host antibodies. Biofilm formation can protect from host phagocytes and antibiotics. Intracellular survival can avoid exposure to host complement and cytokines. Resistance to antimicrobial agents can limit the therapeutic options for treatment.
The immune response to Proteus hauseri infection involves innate and adaptive immunity, which work together to eliminate the bacteria and prevent further infection.
The innate immune response is the first defense against Proteus hauseri infection. It consists of the following:
Physical barriers: The skin and mucous membranes prevent the entry of Proteus hauseri and other bacteria into the body. The urine flow also helps to flush out the bacteria from the urinary tract.
Chemical barriers: The urine’s acidic pH and antimicrobial substances (such as lysozyme, lactoferrin, and defensins) in the urine and mucosal secretions inhibit the growth and survival of Proteus hauseri.
Cellular barriers: The innate immune cells, such as Dendritic cells, natural killer cells, neutrophils, and macrophages, recognize and eliminate Proteus hauseri by phagocytosis, cytotoxicity, and cytokine production. These cells also activate the adaptive immune response by presenting bacterial antigens to T cells.
The adaptive immune response is the second defense against Proteus hauseri infection. It consists of the following:
Humoral immunity: The B cells produce antibodies (such as IgA, IgG, and IgM) that bind to the bacterial antigens and neutralize or enhance their phagocytosis. The antibodies activate the complement system, which can lyse or opsonize the bacteria.
Cell-mediated immunity: The T cells (such as helper T cells and cytotoxic T cells) activate other immune cells or directly kill the infected cells. The helper T cells secrete cytokines that stimulate B cell differentiation, macrophage activation, and inflammation. The cytotoxic T cells induce apoptosis of the infected cells by releasing perforin and granzymes.
Proteus hauseri is the name given to a group of bacteria that belong to the genus Proteus, which can cause various infections in humans, especially in the urinary tract.
Some of the clinical manifestations of Proteus hauseri infections are:
Urinary tract infections (UTIs): Proteus hauseri can cause urethritis, cystitis, pyelonephritis, and kidney stones due to their ability to produce urease, an enzyme that breaks down urea into ammonia and increases the pH of urine. It can lead to the formation of struvite and apatite crystals that can obstruct the urinary tract and cause pain, hematuria, dysuria, and fever.
Wound infections: Proteus hauserican infect wounds and cause cellulitis, abscesses, osteomyelitis, and septic arthritis. These infections can be associated with trauma, surgery, burns, or foreign bodies. They can also cause a fishy odor due to the production of trimethylamine.
Other infections: Proteus hauseri can also cause infections of the biliary tract, gastrointestinal tract, peritoneum, ear, eye, respiratory tract, and bloodstream. These opportunistic infections occur in immunocompromised patients or those with underlying diseases or devices.
Proteus hauseri can be identified by their characteristic morphology, motility, biochemical reactions, and odor. They are usually resistant to many antibiotics and require appropriate antimicrobial therapy based on susceptibility testing.
Proteus hauseri infection can be diagnosed by culturing the sample from the site of infection, such as urine, pus, blood, or sputum, on selective media such as MacConkey agar or blood agar.
Proteus species produce pale or colorless colonies on MacConkey agar and exhibit swarming motility on blood agar. They are also oxidase-negative and urease positive.
The identification of Proteus hauseri can be further confirmed by serological tests based on the O (somatic) and H (flagellar) antigens. Various molecular methods, such as the Polymerase Chain Reaction (PCR) and 16S rRNA sequencing, can also identify Proteus hauseri at the species level.
Prevention is stopping or reducing the risk of infection by microorganisms, such as Proteus hauseri. Some of the prevention measures that can be taken are:
Hygiene: Hygiene is maintaining cleanliness and avoiding contact with contaminated sources. Hygiene can help prevent the entry and transmission of Proteus hauseri and other pathogens. Hygiene measures include washing hands, cooking food properly, disinfecting surfaces and objects, and using sterile equipment.
Antibiotics: Drugs that can potentially kill or inhibit the growth of bacteria. Antibiotics can help treat and prevent Proteus hauseri infections, especially in immunocompromised patients or those with underlying diseases or devices. Antibiotics should be used appropriately based on susceptibility testing and clinical guidelines to avoid resistance and side effects.
Vaccines: Vaccines are substances that can stimulate the immune system to produce antibodies against specific antigens. Vaccines can help prevent and protect against Proteus hauseri infections by inducing immunity and memory. However, no vaccines are currently available for Proteus hauseri, although some research is ongoing.
The epidemiology of Proteus hauseri infection, as this species is relatively rare and often misidentified as Proteus vulgaris bio group 3—however, some general aspects of the epidemiology of Proteus spp. Infection can be applied to Proteus hauseri infection as well.
Proteus spp. is widely distributed in nature and can be found in soil, water, and fecal matter. They are also part of the average human intestinal flora and other Enterobacteriaceae such as Escherichia coli and Klebsiella spp. Proteus spp. are opportunistic pathogens that can cause human infections when they breach the mucosal barriers or enter the bloodstream through wounds, catheters, or other medical devices.
The most common infection caused by Proteus spp. is urinary tract infection (UTI), which may impact any area of the urinary system, including the urethra to the kidney. UTI can occur due to bacterial migration from the rectum to the periurethral and bladder or catheter-associated infection. UTI can also lead to complications such as urolithiasis (stone formation in the kidney or bladder), pyelonephritis (kidney inflammation), cystitis (bladder inflammation), and septicemia (blood infection). Other infections caused by Proteus spp. Including wound infections, burn infections, respiratory tract infections, ear infections, eye infections, meningitis, endocarditis, and osteomyelitis. These infections are more likely to occur in immunocompromised patients or patients with chronic diseases, such as diabetes, liver disease, or renal failure.
Proteus hauseri is one of the five named species of Proteus, along with P. mirabilis, P. vulgaris, P. penneri, and P. myxofaciens. P. hauseri was formerly known as P. vulgaris group 3 or P. vulgaris genomospecies three but was renamed in 2000 based on molecular and phenotypic evidence. P. hauseri has been isolated from various clinical specimens, such as urine, pus, blood, and sputum. It has also been associated with infections such as UTI, wound infection, septicemia, and brain abscess.
The prevalence and incidence of Proteus hauseri infection have yet to be well known, as this species is often misidentified or overlooked in clinical microbiology laboratories. However, some studies have reported that Proteus hauseri accounts for about 1% to 5% of all Proteus isolates from clinical specimens. The risk factors for Proteus hauseri infection are like those for other Proteus spp., such as urinary tract abnormalities, urethral instrumentation, immunosuppression, chronic diseases, and hospitalization.
Proteus hauseri is a Gram-negative bacterium belonging to the family Enterobacteriaceae. It is a motile, facultative anaerobe commonly found in the environment, particularly in water and soil.
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Proteus
Species:Proteus hauseri
Proteus hauseri is a rod-shaped bacterium with a size ranging from 0.5 to 0.8 micrometers in width and 1.5 to 3 micrometers in length. It has a single, polar flagellum, which enables it to exhibit a characteristic swarming motility on agar plates. The flagella allow Proteus hauseri to move rapidly through liquid media or solid surfaces.
Like other Gram-negative bacteria, Proteus hauseri has an outer membrane, a thin peptidoglycan layer in the cell wall, and a plasma membrane. The outer membrane provides an additional protective barrier and contains various proteins and lipopolysaccharides (LPS), which play a role in pathogenesis and immune response.
Proteus hauseri can produce a capsule, a polysaccharide layer that surrounds the cell wall. The capsule helps the bacterium evade the host’s immune system and contributes to its pathogenicity.
Regarding biochemical characteristics, Proteus hauseri is facultatively anaerobic, meaning it can grow both in the presence and absence of oxygen. It is also able to ferment glucose and produce acid and gas. Additionally, Proteus hauseri is urease-positive, which means it can hydrolyze urea and produce ammonia, increasing pH in the surrounding environment.
Proteus hauseri has two antigenic structures: O antigens and H antigens. O antigens are somatic antigens that are part of the cell wall lipopolysaccharide (LPS) and are heat stable. H antigens are flagellar antigens associated with the motility of the bacteria and are heat labile.
Based on these antigens, several serotypes of Proteus hauseri have been recognized, such as O1 to O17, and H2 are all types of atoms. Some of these serotypes cross-react with other bacteria, such as Rickettsia spp., Salmonella spp., and Shigella spp.
Some strains of Proteus hauseri that have been isolated and characterized are:
ATCC 700826T, the strain type of Proteus hauseri, was isolated from a human wound in the USA. This strain has been whole genome sequenced and has applications in quality control and water testing.
NCTC 4175, a Proteus hauseri strain isolated from a human urine sample in Germany. This strain is also known as strain Lehmann and has been whole genome sequenced.
CDC 1732-80, a Proteus hauseri strain isolated from a human blood sample in the USA.
CIP 106868, a Proteus hauseri strain isolated from a human urine sample in France.
DSM 14437, a Proteus hauseri strain isolated from a human wound in the USA.
Pathogenesis is the process by which a microorganism causes disease in a host. The pathogenesis of Proteus hauseri infections involves the following steps:
Entry:Proteus hauseri can enter the host through different routes, such as ingesting contaminated food or water, direct contact with infected people or animals, or colonization of medical devices such as catheters or nasogastric tubes.
Adhesion:Proteus hauseri can adhere to the host cells and tissues using various adhesins, such as pili (fimbriae), flagella, and outer membrane proteins. Adhesion is essential for colonization, invasion, and biofilm formation.
Invasion:Proteus hauseri can invade the host cells and tissues using various mechanisms, such as endocytosis, transcytosis, paracellular migration, or direct penetration. Invasion is essential for escaping the host immune system and reaching deeper sites of infection.
Damage:Proteus hauseri can damage the host cells and tissues using various mechanisms, such as the production of urease, proteases, hemolysins, and lipases. Ureases can increase urine pH and cause kidney stones and tissue damage. Proteases can degrade host proteins and extracellular matrix. Hemolysins can lyse host red blood cells and cause anemia. Lipases can hydrolyze host lipids and cause inflammation.
Evasion:Proteus hauseri can evade the host immune system using various mechanisms, such as antigenic variation, biofilm formation, intracellular survival, and resistance to antimicrobial agents. Antigenic variation can prevent recognition by host antibodies. Biofilm formation can protect from host phagocytes and antibiotics. Intracellular survival can avoid exposure to host complement and cytokines. Resistance to antimicrobial agents can limit the therapeutic options for treatment.
The immune response to Proteus hauseri infection involves innate and adaptive immunity, which work together to eliminate the bacteria and prevent further infection.
The innate immune response is the first defense against Proteus hauseri infection. It consists of the following:
Physical barriers: The skin and mucous membranes prevent the entry of Proteus hauseri and other bacteria into the body. The urine flow also helps to flush out the bacteria from the urinary tract.
Chemical barriers: The urine’s acidic pH and antimicrobial substances (such as lysozyme, lactoferrin, and defensins) in the urine and mucosal secretions inhibit the growth and survival of Proteus hauseri.
Cellular barriers: The innate immune cells, such as Dendritic cells, natural killer cells, neutrophils, and macrophages, recognize and eliminate Proteus hauseri by phagocytosis, cytotoxicity, and cytokine production. These cells also activate the adaptive immune response by presenting bacterial antigens to T cells.
The adaptive immune response is the second defense against Proteus hauseri infection. It consists of the following:
Humoral immunity: The B cells produce antibodies (such as IgA, IgG, and IgM) that bind to the bacterial antigens and neutralize or enhance their phagocytosis. The antibodies activate the complement system, which can lyse or opsonize the bacteria.
Cell-mediated immunity: The T cells (such as helper T cells and cytotoxic T cells) activate other immune cells or directly kill the infected cells. The helper T cells secrete cytokines that stimulate B cell differentiation, macrophage activation, and inflammation. The cytotoxic T cells induce apoptosis of the infected cells by releasing perforin and granzymes.
Proteus hauseri is the name given to a group of bacteria that belong to the genus Proteus, which can cause various infections in humans, especially in the urinary tract.
Some of the clinical manifestations of Proteus hauseri infections are:
Urinary tract infections (UTIs): Proteus hauseri can cause urethritis, cystitis, pyelonephritis, and kidney stones due to their ability to produce urease, an enzyme that breaks down urea into ammonia and increases the pH of urine. It can lead to the formation of struvite and apatite crystals that can obstruct the urinary tract and cause pain, hematuria, dysuria, and fever.
Wound infections: Proteus hauserican infect wounds and cause cellulitis, abscesses, osteomyelitis, and septic arthritis. These infections can be associated with trauma, surgery, burns, or foreign bodies. They can also cause a fishy odor due to the production of trimethylamine.
Other infections: Proteus hauseri can also cause infections of the biliary tract, gastrointestinal tract, peritoneum, ear, eye, respiratory tract, and bloodstream. These opportunistic infections occur in immunocompromised patients or those with underlying diseases or devices.
Proteus hauseri can be identified by their characteristic morphology, motility, biochemical reactions, and odor. They are usually resistant to many antibiotics and require appropriate antimicrobial therapy based on susceptibility testing.
Proteus hauseri infection can be diagnosed by culturing the sample from the site of infection, such as urine, pus, blood, or sputum, on selective media such as MacConkey agar or blood agar.
Proteus species produce pale or colorless colonies on MacConkey agar and exhibit swarming motility on blood agar. They are also oxidase-negative and urease positive.
The identification of Proteus hauseri can be further confirmed by serological tests based on the O (somatic) and H (flagellar) antigens. Various molecular methods, such as the Polymerase Chain Reaction (PCR) and 16S rRNA sequencing, can also identify Proteus hauseri at the species level.
Prevention is stopping or reducing the risk of infection by microorganisms, such as Proteus hauseri. Some of the prevention measures that can be taken are:
Hygiene: Hygiene is maintaining cleanliness and avoiding contact with contaminated sources. Hygiene can help prevent the entry and transmission of Proteus hauseri and other pathogens. Hygiene measures include washing hands, cooking food properly, disinfecting surfaces and objects, and using sterile equipment.
Antibiotics: Drugs that can potentially kill or inhibit the growth of bacteria. Antibiotics can help treat and prevent Proteus hauseri infections, especially in immunocompromised patients or those with underlying diseases or devices. Antibiotics should be used appropriately based on susceptibility testing and clinical guidelines to avoid resistance and side effects.
Vaccines: Vaccines are substances that can stimulate the immune system to produce antibodies against specific antigens. Vaccines can help prevent and protect against Proteus hauseri infections by inducing immunity and memory. However, no vaccines are currently available for Proteus hauseri, although some research is ongoing.
The epidemiology of Proteus hauseri infection, as this species is relatively rare and often misidentified as Proteus vulgaris bio group 3—however, some general aspects of the epidemiology of Proteus spp. Infection can be applied to Proteus hauseri infection as well.
Proteus spp. is widely distributed in nature and can be found in soil, water, and fecal matter. They are also part of the average human intestinal flora and other Enterobacteriaceae such as Escherichia coli and Klebsiella spp. Proteus spp. are opportunistic pathogens that can cause human infections when they breach the mucosal barriers or enter the bloodstream through wounds, catheters, or other medical devices.
The most common infection caused by Proteus spp. is urinary tract infection (UTI), which may impact any area of the urinary system, including the urethra to the kidney. UTI can occur due to bacterial migration from the rectum to the periurethral and bladder or catheter-associated infection. UTI can also lead to complications such as urolithiasis (stone formation in the kidney or bladder), pyelonephritis (kidney inflammation), cystitis (bladder inflammation), and septicemia (blood infection). Other infections caused by Proteus spp. Including wound infections, burn infections, respiratory tract infections, ear infections, eye infections, meningitis, endocarditis, and osteomyelitis. These infections are more likely to occur in immunocompromised patients or patients with chronic diseases, such as diabetes, liver disease, or renal failure.
Proteus hauseri is one of the five named species of Proteus, along with P. mirabilis, P. vulgaris, P. penneri, and P. myxofaciens. P. hauseri was formerly known as P. vulgaris group 3 or P. vulgaris genomospecies three but was renamed in 2000 based on molecular and phenotypic evidence. P. hauseri has been isolated from various clinical specimens, such as urine, pus, blood, and sputum. It has also been associated with infections such as UTI, wound infection, septicemia, and brain abscess.
The prevalence and incidence of Proteus hauseri infection have yet to be well known, as this species is often misidentified or overlooked in clinical microbiology laboratories. However, some studies have reported that Proteus hauseri accounts for about 1% to 5% of all Proteus isolates from clinical specimens. The risk factors for Proteus hauseri infection are like those for other Proteus spp., such as urinary tract abnormalities, urethral instrumentation, immunosuppression, chronic diseases, and hospitalization.
Classification and Structure
Proteus hauseri is a Gram-negative bacterium belonging to the family Enterobacteriaceae. It is a motile, facultative anaerobe commonly found in the environment, particularly in water and soil.
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Proteus
Species:Proteus hauseri
Proteus hauseri is a rod-shaped bacterium with a size ranging from 0.5 to 0.8 micrometers in width and 1.5 to 3 micrometers in length. It has a single, polar flagellum, which enables it to exhibit a characteristic swarming motility on agar plates. The flagella allow Proteus hauseri to move rapidly through liquid media or solid surfaces.
Like other Gram-negative bacteria, Proteus hauseri has an outer membrane, a thin peptidoglycan layer in the cell wall, and a plasma membrane. The outer membrane provides an additional protective barrier and contains various proteins and lipopolysaccharides (LPS), which play a role in pathogenesis and immune response.
Proteus hauseri can produce a capsule, a polysaccharide layer that surrounds the cell wall. The capsule helps the bacterium evade the host’s immune system and contributes to its pathogenicity.
Regarding biochemical characteristics, Proteus hauseri is facultatively anaerobic, meaning it can grow both in the presence and absence of oxygen. It is also able to ferment glucose and produce acid and gas. Additionally, Proteus hauseri is urease-positive, which means it can hydrolyze urea and produce ammonia, increasing pH in the surrounding environment.
Antigenic Types
Proteus hauseri has two antigenic structures: O antigens and H antigens. O antigens are somatic antigens that are part of the cell wall lipopolysaccharide (LPS) and are heat stable. H antigens are flagellar antigens associated with the motility of the bacteria and are heat labile.
Based on these antigens, several serotypes of Proteus hauseri have been recognized, such as O1 to O17, and H2 are all types of atoms. Some of these serotypes cross-react with other bacteria, such as Rickettsia spp., Salmonella spp., and Shigella spp.
Some strains of Proteus hauseri that have been isolated and characterized are:
ATCC 700826T, the strain type of Proteus hauseri, was isolated from a human wound in the USA. This strain has been whole genome sequenced and has applications in quality control and water testing.
NCTC 4175, a Proteus hauseri strain isolated from a human urine sample in Germany. This strain is also known as strain Lehmann and has been whole genome sequenced.
CDC 1732-80, a Proteus hauseri strain isolated from a human blood sample in the USA.
CIP 106868, a Proteus hauseri strain isolated from a human urine sample in France.
DSM 14437, a Proteus hauseri strain isolated from a human wound in the USA.
Pathogenesis
Pathogenesis is the process by which a microorganism causes disease in a host. The pathogenesis of Proteus hauseri infections involves the following steps:
Entry:Proteus hauseri can enter the host through different routes, such as ingesting contaminated food or water, direct contact with infected people or animals, or colonization of medical devices such as catheters or nasogastric tubes.
Adhesion:Proteus hauseri can adhere to the host cells and tissues using various adhesins, such as pili (fimbriae), flagella, and outer membrane proteins. Adhesion is essential for colonization, invasion, and biofilm formation.
Invasion:Proteus hauseri can invade the host cells and tissues using various mechanisms, such as endocytosis, transcytosis, paracellular migration, or direct penetration. Invasion is essential for escaping the host immune system and reaching deeper sites of infection.
Damage:Proteus hauseri can damage the host cells and tissues using various mechanisms, such as the production of urease, proteases, hemolysins, and lipases. Ureases can increase urine pH and cause kidney stones and tissue damage. Proteases can degrade host proteins and extracellular matrix. Hemolysins can lyse host red blood cells and cause anemia. Lipases can hydrolyze host lipids and cause inflammation.
Evasion:Proteus hauseri can evade the host immune system using various mechanisms, such as antigenic variation, biofilm formation, intracellular survival, and resistance to antimicrobial agents. Antigenic variation can prevent recognition by host antibodies. Biofilm formation can protect from host phagocytes and antibiotics. Intracellular survival can avoid exposure to host complement and cytokines. Resistance to antimicrobial agents can limit the therapeutic options for treatment.
Host Defenses
The immune response to Proteus hauseri infection involves innate and adaptive immunity, which work together to eliminate the bacteria and prevent further infection.
The innate immune response is the first defense against Proteus hauseri infection. It consists of the following:
Physical barriers: The skin and mucous membranes prevent the entry of Proteus hauseri and other bacteria into the body. The urine flow also helps to flush out the bacteria from the urinary tract.
Chemical barriers: The urine’s acidic pH and antimicrobial substances (such as lysozyme, lactoferrin, and defensins) in the urine and mucosal secretions inhibit the growth and survival of Proteus hauseri.
Cellular barriers: The innate immune cells, such as Dendritic cells, natural killer cells, neutrophils, and macrophages, recognize and eliminate Proteus hauseri by phagocytosis, cytotoxicity, and cytokine production. These cells also activate the adaptive immune response by presenting bacterial antigens to T cells.
The adaptive immune response is the second defense against Proteus hauseri infection. It consists of the following:
Humoral immunity: The B cells produce antibodies (such as IgA, IgG, and IgM) that bind to the bacterial antigens and neutralize or enhance their phagocytosis. The antibodies activate the complement system, which can lyse or opsonize the bacteria.
Cell-mediated immunity: The T cells (such as helper T cells and cytotoxic T cells) activate other immune cells or directly kill the infected cells. The helper T cells secrete cytokines that stimulate B cell differentiation, macrophage activation, and inflammation. The cytotoxic T cells induce apoptosis of the infected cells by releasing perforin and granzymes.
Clinical manifestations
Proteus hauseri is the name given to a group of bacteria that belong to the genus Proteus, which can cause various infections in humans, especially in the urinary tract.
Some of the clinical manifestations of Proteus hauseri infections are:
Urinary tract infections (UTIs): Proteus hauseri can cause urethritis, cystitis, pyelonephritis, and kidney stones due to their ability to produce urease, an enzyme that breaks down urea into ammonia and increases the pH of urine. It can lead to the formation of struvite and apatite crystals that can obstruct the urinary tract and cause pain, hematuria, dysuria, and fever.
Wound infections: Proteus hauserican infect wounds and cause cellulitis, abscesses, osteomyelitis, and septic arthritis. These infections can be associated with trauma, surgery, burns, or foreign bodies. They can also cause a fishy odor due to the production of trimethylamine.
Other infections: Proteus hauseri can also cause infections of the biliary tract, gastrointestinal tract, peritoneum, ear, eye, respiratory tract, and bloodstream. These opportunistic infections occur in immunocompromised patients or those with underlying diseases or devices.
Proteus hauseri can be identified by their characteristic morphology, motility, biochemical reactions, and odor. They are usually resistant to many antibiotics and require appropriate antimicrobial therapy based on susceptibility testing.
Diagnosis
Proteus hauseri infection can be diagnosed by culturing the sample from the site of infection, such as urine, pus, blood, or sputum, on selective media such as MacConkey agar or blood agar.
Proteus species produce pale or colorless colonies on MacConkey agar and exhibit swarming motility on blood agar. They are also oxidase-negative and urease positive.
The identification of Proteus hauseri can be further confirmed by serological tests based on the O (somatic) and H (flagellar) antigens. Various molecular methods, such as the Polymerase Chain Reaction (PCR) and 16S rRNA sequencing, can also identify Proteus hauseri at the species level.
Control
Prevention is stopping or reducing the risk of infection by microorganisms, such as Proteus hauseri. Some of the prevention measures that can be taken are:
Hygiene: Hygiene is maintaining cleanliness and avoiding contact with contaminated sources. Hygiene can help prevent the entry and transmission of Proteus hauseri and other pathogens. Hygiene measures include washing hands, cooking food properly, disinfecting surfaces and objects, and using sterile equipment.
Antibiotics: Drugs that can potentially kill or inhibit the growth of bacteria. Antibiotics can help treat and prevent Proteus hauseri infections, especially in immunocompromised patients or those with underlying diseases or devices. Antibiotics should be used appropriately based on susceptibility testing and clinical guidelines to avoid resistance and side effects.
Vaccines: Vaccines are substances that can stimulate the immune system to produce antibodies against specific antigens. Vaccines can help prevent and protect against Proteus hauseri infections by inducing immunity and memory. However, no vaccines are currently available for Proteus hauseri, although some research is ongoing.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
